Skip to content
TrialScanner

NCT03667716

COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.

Phase 1CompletedCGENLeadBMYCollaborator

Registry record

Lead sponsor
Compugen Ltd
Conditions
Advanced Cancer; Ovarian Cancer; Breast Cancer; Lung Cancer; Endometrial Cancer
Primary completion
Jan 30, 2024Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03667716 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03667716: COM701 (an Inhibitor of... | TrialScanner